Switchpoint Bio: Funding, Investors & Team (Sep 2026)
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Switchpoint Bio has raised $5.3M across 1 funding round on record, the most recent an undisclosed round of $5.3M announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Switchpoint Bio Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Switchpoint Bio Funding Rounds
Switchpoint Bio Founders and Leadership Team
Contact details for the Switchpoint Bio team: 1 has a LinkedIn profile.
Start 14-day free trial →Switchpoint Bio Funding Compared to Other Biotechnology Startups
Switchpoint Bio's latest round of $5.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Switchpoint Bio in Biotechnology and Wilmington
Companies Similar to Switchpoint Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Switchpoint Bio Funding FAQs
What does Switchpoint Bio do?
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
How much funding has Switchpoint Bio raised?
Switchpoint Bio has raised $5.3M across 1 round on record. The most recent is an undisclosed round of $5.3M announced in Mar 2026.
When did Switchpoint Bio last raise funding?
Switchpoint Bio's most recent funding round on record is an undisclosed round of $5.3M, announced in Mar 2026.
Who founded Switchpoint Bio?
FundedIQ lists Samuel Myllykangas (Founder) at Switchpoint Bio.
Where is Switchpoint Bio headquartered?
Switchpoint Bio is based in Wilmington, Delaware, United States.
How many employees does Switchpoint Bio have?
Switchpoint Bio is in the 1-10 employee band.
How does Switchpoint Bio's funding compare to other Biotechnology startups?
Switchpoint Bio's latest round of $5.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Switchpoint Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Switchpoint Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.